Washington, D.C. (June 13, 2013)
Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO), today issued the following statement on the U.S. Supreme Court’s decision regarding Myriad Genetics’ patent claims on isolated DNA molecules: Continue reading
BioPharm Insight Profiles MSDxContinue reading
RiboMed and Austrian Institute of Technology Partner on Epigenetic Tests for Early Lung Cancer Detection, Sub-typing and Drug Response.Continue reading
Only Targeted Improvements NeededContinue reading
Dr. Anita Koshy sees a common and typically harmless brain parasite as a potential key to unlocking secrets of neurobiology that can be used to intervene in diseases such as Alzheimer’s and multiple sclerosis.Continue reading
A new global assessment helps scientists explain why genetically modified crops have suppressed some pests for longer than a decade, while others adapted in a few years.Continue reading
Dr. John-Michael Sauer, a 15-year veteran of pharmaceutical research and development, will lead the Predictive Safety Testing ConsortiumContinue reading
Arizona is home to a leading “emerging bioscience sector”…yet for most non-Arizonans, and many residents of the state, the industry and its value as a scientific and economic contributor is still unrecognized. Continue reading
25% of this year’s 40 Under 40 come from AZBio Member CompaniesContinue reading
Research by UA medical student Lucy Han finds that implementing recommended pulse oximetry screening guidelines is feasible at Tucson’s elevation. Continue reading